Skip to content
Brand AI

Mitsubishi Tanabe Pharma

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    LEO Pharma acquires worldwide rights to dersimelagon from Tanabe Pharma

    LEO Pharma agreed to acquire worldwide rights to dersimelagon, an oral once-daily MC1R agonist being developed for EPP and XLP, from Tanabe Pharma for up to $435m in up-front and near-term milestone payments plus potential downstream milestones and tiered royalties on net sales.

    Source